Leveraging quality improvement to promote health equity: standardization of prenatal aspirin recommendations
BMC Pregnancy and Childbirth · 08.09.2023 · 23 (1)
DOI: 10.1186/s12884-023-05922-w ↗Kurz gefasst
Fachartikel in der Zeitschrift BMC Pregnancy and Childbirth, online erschienen am 08.09.2023. Verfasst von Maya E Gross und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA. maya.e.groos@gmail.com. Hauptthemen laut MEDLINE: Aspirin, Pre-Eclampsia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Wisconsin-Madison.
Abstract (Originalsprache)
Objective
Aspirin (ASA) is recommended for patients at elevated risk of preeclampsia. Limited data exists on adherence to guidelines for ASA prescription. This project evaluates the implementation of a standardized approach to ASA prescription in an academic OB/Gyn practice.
Methods
We implemented a quality improvement project to evaluate compliance with the United States Preventative Services Task Force (USPSTF) recommendations for ASA to prevent preeclampsia. Pre-intervention, we analyzed prescription adherence at 201 New Obstetric (NOB) visits. A multi-step intervention was then implemented at 199 NOB visits. Nurses utilized a checklist created from USPSTF guidelines to identify high-risk patients, defined as having ≥1 high-risk factor or ≥2 moderate-risk factors. ASA orders were placed by physicians. A Plan-Do-Study-Act (PDSA) cycle was performed, and changes implemented. Primary outcome was percent of patients screened at RN intake visit (goal = 90%). Secondary outcomes were percent of patients who screened positive that received the ASA recommendation (goal = 80%) and percent screened and recommended by race.
Results
Pre-intervention, 47% of patients met criteria for ASA and 28% received a documented recommendation. Post-intervention, 99% were screened. Half (48%) met criteria for an ASA recommendation and 79% received a recommendation (p = < 0.001). Rates of appropriate recommendation did not differ by Black (80%) vs. non-Black (79%) status (p = 0.25). Subsequent PDSA cycles for 12 months neared 100% RN screening rates. Physicians correctly recommended ASA 80–100% of the time.
Conclusion
It is feasible, sustainable and equitable to standardize screening and implementation of ASA to patients at high risk for preeclampsia. Providers can easily reproduce our processes to improve delivery of equitable and reliable preventative obstetric care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA. maya.e.groos@gmail.com.
- Department of Obstetrics and Gynecology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
- Department of Obstetrics and Gynecology, George Washington School of Medicine, Washington, DC, USA.
Förderung
- University of Wisconsin-Madison
Zitieren
APA
Gross, M. E., Godecker, A., Hughes, A., & Sampene, K. (2023). Leveraging quality improvement to promote health equity: standardization of prenatal aspirin recommendations. BMC Pregnancy and Childbirth, 23(1). https://doi.org/10.1186/s12884-023-05922-w
Vancouver
Gross ME, Godecker A, Hughes A, Sampene K. Leveraging quality improvement to promote health equity: standardization of prenatal aspirin recommendations. BMC Pregnancy and Childbirth. 2023;23(1). doi:10.1186/s12884-023-05922-w
BibTeX
@article{Gross2023,
author = {Gross, Maya E and Godecker, Amy and Hughes, Ainsley and Sampene, Katherine},
title = {Leveraging quality improvement to promote health equity: standardization of prenatal aspirin recommendations},
journal = {BMC Pregnancy and Childbirth},
year = {2023},
volume = {23},
number = {1},
doi = {10.1186/s12884-023-05922-w}
}
EUVIMED